WO2024176164 - SOLID STATE FORM OF PIRTOBRUTINIB
National phase entry is expected:
Publication Number
WO/2024/176164
Publication Date
29.08.2024
International Application No.
PCT/IB2024/051719
International Filing Date
22.02.2024
Title **
[English]
SOLID STATE FORM OF PIRTOBRUTINIB
[French]
FORME À L'ÉTAT SOLIDE DE PIRTOBRUTINIB
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
BENÝŠEK BÁRTOVÁ, Adela
KOLESA, Pavel
JEGOROV, Alexandr
KORDIC, Lorena
MIHOVILOVIĆ, Moris
KUJUNDŽIĆ MILKOVIĆ, Tanja
Priority Data
63/447,376
22.02.2023
US
63/553,747
15.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2603 | |
| EPO | Filing, Examination, Granting | 14221 | |
| Japan | Filing, Examination, Granting | 2480 | |
| South Korea | Filing, Examination, Granting | 2714 | |
| USA | Filing, Examination, Granting | 10540 |
Total:
32,558
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure encompasses a solid state form of Pirtobrutinib for use as BRK inhibitor. Formula (I)[French]
La présente divulgation concerne une forme à l'état solide de Pirtobrutinib destinée à être utilisée en tant qu'inhibiteur de BRK. Formule (I)